Noile-Immune Biotech Inc.
ノイルイミューン・バイオテック株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4893
FY2025 · 2025-12-31
| Gross margin | — |
| Operating margin | — |
| Net margin | — |
| Return on equity | — |
| Return on assets | -19.8% |
| Revenue growth (YoY) | — |
| EPS (basic) | ¥-18.33 |
| EPS growth (YoY) | — |
| Current ratio | 53.54x |
| Equity ratio | 97.8% |
| Book value / share | ¥90.65 |
| Free cash flow | — |